Latest News
Featured
We’re excited to share that Tenvie announcements have been picked up in the press recently! The promotion of Tony Estrada by Tenvie’s Board was featured in Yahoo! Finance, BioCentury, and BioWorld Our great news has also been picked up by Endpoints News, Fierce Biotech’s Chutes and Ladders, as well as STAT’s Up and down the […]
Proven drug development leader to drive company’s pipeline of highly CNS-penetrant and precision-designed peripherally restricted small molecules toward clinical milestones SOUTH SAN FRANCISCO, July 23, 2025 – Tenvie Therapeutics, a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases, today announced the appointment of Tony Estrada, Ph.D., as President and Chief […]
Welcome to the launch of Tenvie Therapeutics! We are thrilled to announce the official launch of Tenvie with a commitment to transform the treatment of neurological diseases.Follow us on our journey, covered by Global Newswire, STAT, Endpoints News, Fierce Biotech, and the San Francisco Business Times
Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases Led by expert R&D leadership team with proven ability to develop therapies for CNS and peripheral diseases ARCH Venture Partners, F-Prime Capital, and Mubadala Capital lead $200 million investment to fuel acceleration of Tenvie into a multi-clinical asset company SOUTH SAN FRANCISCO, January […]